IL11 and pulmonary fibrosis: Following nebulization, the LNPs effectively deliver IL‐11 scFv mRNA into the lungs and produce antibody to neutralize IL‐11, significantly ameliorating lung fibrosis through suppression of fibroblast activation and ECM deposition.